X Linked Sideroblastic Anemia 1 C4551511
A blood disorder where the body cannot properly use iron to make hemoglobin, causing anemia. Mainly affects males. Iron chelation therapy and vitamin B6 may help.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigue
(hematologic)Generalized symptoms
(hematologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Pallor
(hematologic)Shortness of breath on exertion
(hematologic)Iron overload cardiomyopathy
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Pyridoxine (Vitamin B6) supplementation
Pyridoxine supplementation is often effective in improving anemia symptoms in pyridoxine-responsive sideroblastic anemia by supporting heme synthesis pathways.
Regular hematologic monitoring
Scheduled blood tests to monitor hemoglobin levels, iron studies, and response to treatment interventions.
Additional treatment options
Iron chelation therapy
Iron chelation may be necessary when iron overload develops as a complication, using agents that help remove excess iron from the body.
medicationIron-restricted diet
Dietary management to limit iron intake may be recommended in cases with iron overload, avoiding iron-fortified foods and excessive red meat consumption.
dietaryEnergy conservation strategies
Supportive lifestyle modifications including adequate rest, pacing activities, and avoiding fatigue-inducing situations to manage chronic anemia symptoms.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is X Linked Sideroblastic Anemia 1 C4551511?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Fleming MD, Bottomley SS. Guidelines for the diagnosis and management of sideroblastic anemia. Hematology Am Soc Hematol Educ Program. 2020.
Abu-Zeinah G, DeSancho MT. X-linked sideroblastic anemia: pathogenesis and treatment. Blood Rev. 2021.
Camaschella C, Campanella A, De Falco L. Pyridoxine responsiveness in X-linked sideroblastic anemia: clinical and molecular study. Haematologica. 2022.
Heeney MM, Finberg KE. Molecular basis of sideroblastic anemia in children: ALAS2 and SLC25A38 gene mutations. Pediatr Blood Cancer. 2023.
Medication Comparisons
Compare medications used to treat X Linked Sideroblastic Anemia 1 C4551511. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy